Conventional biotechnology based industries are already established economic activities in India. Facilities have also been set up for the production of restriction endonucleases, oligonucleotides, culture media, plastic wares, micro pipettes etc., However recombinant biotechnology products are still at the research stage and market demand is met through imports. The bulk of the R & D resources for product development are currently being provided by the Government, which has also taken steps to develop trained man power, set up the infrastructure for research, and has organised demonstration projects for faster dissemination of research results to industry. The consumption of biotech products will rise from Rs. 18.74 billion in 1992 to Rs. 55.47 billion in 2000 and the expected additional investment is anticipated to be Rs. 14 billion during the next 8 years.